Evidence map›Paper›PMID 32367468›Full record

ReviewInternal and emergency medicine2020

Cardio-metabolic problem in Egypt.

Mona Amin, Amal Radwan, Afaf Hemeda

Abstract readReview
PubMed Publisher
In one paragraph

Review in Internal and emergency medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mona AminInternal Medicine, Egyptian Society of Internal Medicine, Cairo University, Giza, Egypt. monasleman@hotmail.com.
Amal RadwanInternal Medicine, Egyptian Society of Internal Medicine, Cairo University, Giza, Egypt.
Afaf HemedaInternal Medicine, Egyptian Society of Internal Medicine, Cairo University, Giza, Egypt.
Cairo University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thirty years ago, chronic conditions such as diabetes, heart disease, and obesity accounted for less than 45% of the global disease burden. Today, they are the leading causes of death and disability worldwide, having surpassed infectious diseases such as HIV/AIDS and malaria. We have understood for decades the roles of 'classical' risk factors including elevated LDL-cholesterol, hypertension, elevated blood glucose, and smoking in the pathogenesis of cardiovascular disease. More recent research is continuing to define the contribution of other emerging factors to the risk of developing cardiovascular disease, particularly abdominal obesity that is associated with atherogenic dyslipidemia, insulin resistance, chronic inflammation, and prothrombotic state. All these factors constitute the global cardiometabolic risk that plays a significant role in development of cardiovascular disease.

Indexed as

Heart Disease Risk FactorsCardiovascular DiseasesEgyptHumansMetabolic SyndromePrevalenceCardio-metabolicCardiovascular diseasesInsulin resistance

Identifiers

PMID32367468
OpenAlexW3020952079

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.